Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets

被引:2
|
作者
Nisar, Ayesha [1 ,2 ,3 ]
Khan, Sawar [4 ,5 ]
Li, Wen [6 ]
Hu, Li [1 ,2 ,3 ]
Samarawickrama, Priyadarshani Nadeeshika [1 ,2 ,3 ]
Gold, Naheemat Modupeola [1 ,2 ,3 ]
Zi, Meiting [1 ,3 ]
Mehmood, Sardar Azhar [7 ]
Miao, Jiarong [8 ]
He, Yonghan [1 ,2 ,3 ]
机构
[1] Chinese Acad Sci, Kunming Inst Zool, Key Lab Genet Evolut & Anim Models, KIZ CUHK Joint Lab Bioresources & Mol Res Common D, Kunming, Yunnan, Peoples R China
[2] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Peoples R China
[3] Chinese Acad Sci, Kunming Inst Zool, Key Lab Hlth Aging Res Yunnan Prov, Kunming, Yunnan, Peoples R China
[4] Cent South Univ, Sch Life Sci, Dept Cell Biol, Changsha, Hunan, Peoples R China
[5] Univ Lahore, Inst Mol Biol & Biotechnol, Lahore, Pakistan
[6] Dali Univ, Affiliated Hosp 2, Peoples Hosp Yunnan Prov 3, Dept Endocrinol, Kunming, Yunnan, Peoples R China
[7] Hazara Univ, Dept Zool, Mansehra, Pakistan
[8] Kunming Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Kunming, Yunnan, Peoples R China
来源
MEDCOMM | 2024年 / 5卷 / 11期
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
age-related disease; aging; hypoxia; mechanism; therapeutic target; NF-KAPPA-B; CHRONIC INTERMITTENT HYPOXIA; INDUCED TAU PHOSPHORYLATION; ALTITUDE CEREBRAL EDEMA; OBSTRUCTIVE SLEEP-APNEA; SENESCENT CELLS; CELLULAR SENESCENCE; ALZHEIMERS-DISEASE; INDUCIBLE FACTORS; STEM-CELLS;
D O I
10.1002/mco2.786
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aging is a complex biological process characterized by the gradual decline of cellular functions, increased susceptibility to diseases, and impaired stress responses. Hypoxia, defined as reduced oxygen availability, is a critical factor that influences aging through molecular pathways involving hypoxia-inducible factors (HIFs), oxidative stress, inflammation, and epigenetic modifications. This review explores the interconnected roles of hypoxia in aging, highlighting how hypoxic conditions exacerbate cellular damage, promote senescence, and contribute to age-related pathologies, including cardiovascular diseases, neurodegenerative disorders, cancer, metabolic dysfunctions, and pulmonary conditions. By examining the molecular mechanisms linking hypoxia to aging, we identify key pathways that serve as potential therapeutic targets. Emerging interventions such as HIF modulators, antioxidants, senolytics, and lifestyle modifications hold promise in mitigating the adverse effects of hypoxia on aging tissues. However, challenges such as the heterogeneity of aging, lack of reliable biomarkers, and safety concerns regarding hypoxia-targeted therapies remain. This review emphasizes the need for personalized approaches and advanced technologies to develop effective antiaging interventions. By integrating current knowledge, this review provides a comprehensive framework that underscores the importance of targeting hypoxia-induced pathways to enhance healthy aging and reduce the burden of age-related diseases. Aging involves the decline of cellular functions and increased disease susceptibility. Hypoxia, or reduced oxygen availability, accelerates aging by influencing pathways like hypoxia-inducible factors (HIFs), oxidative stress, and inflammation. This review highlights how hypoxia exacerbates cellular damage, promotes senescence, and contributes to age-related diseases. Emerging therapies, such as HIF modulators and senolytics, show promise in mitigating hypoxia's impact on aging. image
引用
收藏
页数:27
相关论文
共 50 条
  • [1] Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
    Chen, Runkai
    Zhang, Hongrui
    Tang, Botao
    Luo, Yukun
    Yang, Yufei
    Zhong, Xin
    Chen, Sifei
    Xu, Xinjie
    Huang, Shengkang
    Liu, Canzhao
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [2] Immune system modulation in aging: Molecular mechanisms and therapeutic targets
    Cisneros, Bulmaro
    Garcia-Aguirre, Ian
    Unzueta, Juan
    Arrieta-Cruz, Isabel
    Gonzalez-Morales, Oscar
    Dominguez-Larrieta, Juan M.
    Tamez-Gonzalez, Aura
    Leyva-Gomez, Gerardo
    Magana, Jonathan J.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [3] Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets
    Lijun Dai
    Li Zou
    Lanxia Meng
    Guifen Qiang
    Mingmin Yan
    Zhentao Zhang
    Molecular Neurobiology, 2021, 58 : 2183 - 2201
  • [4] Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets
    Dai, Lijun
    Zou, Li
    Meng, Lanxia
    Qiang, Guifen
    Yan, Mingmin
    Zhang, Zhentao
    MOLECULAR NEUROBIOLOGY, 2021, 58 (05) : 2183 - 2201
  • [5] Aging and cognitive resilience: Molecular mechanisms as new potential therapeutic targets
    Cordeiro, Ana
    Gomes, Catarina
    Bicker, Joana
    Fortuna, Ana
    DRUG DISCOVERY TODAY, 2024, 29 (09)
  • [6] Hypoxia signaling in human diseases and therapeutic targets
    Lee, Jae W.
    Ko, Junsuk
    Ju, Cynthia
    Eltzschig, Holger K.
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 51 (6): : 1 - 13
  • [7] Hypoxia signaling in human diseases and therapeutic targets
    Jae W. Lee
    Junsuk Ko
    Cynthia Ju
    Holger K. Eltzschig
    Experimental & Molecular Medicine, 2019, 51 : 1 - 13
  • [8] GSDMD-mediated pyroptosis: molecular mechanisms, diseases and therapeutic targets
    Li, Yujuan
    Guo, Bin
    MOLECULAR BIOMEDICINE, 2025, 6 (01):
  • [9] Inflammatory Related Cardiovascular Diseases: From Molecular Mechanisms to Therapeutic Targets
    Sardu, Celestino
    Paolisso, Giuseppe
    Marfella, Raffaele
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (22) : 2565 - 2573
  • [10] The Impact of Aging on Neurological Diseases in the Elderly: Molecular Mechanisms and Therapeutic Perspectives
    Zhou, Dan
    Lin, Yumeng
    Han, Zhongyu
    Zhang, Zhuyun
    Lin, Le
    Lin, Shichong
    Yang, Qianke
    AGING AND DISEASE, 2024,